| scholarly article | Q13442814 |
| P50 | author | Ann Marie Schmidt | Q89261684 |
| Judyta Juranek | Q56907008 | ||
| P2093 | author name string | Michael MacLean | |
| Julia Derk | |||
| P2860 | cites work | TREM2 Variants in Alzheimer's Disease | Q22250873 |
| Variant of TREM2 Associated with the Risk of Alzheimer's Disease | Q22250874 | ||
| RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease | Q24314906 | ||
| Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42 | Q24323192 | ||
| ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models | Q24628845 | ||
| Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice. | Q27319831 | ||
| The 1.5 A Crystal Structure of Human Receptor for Advanced Glycation Endproducts (RAGE) Ectodomains Reveals Unique Features Determining Ligand Binding | Q27664995 | ||
| Structural Basis for Ligand Recognition and Activation of RAGE | Q27665039 | ||
| Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models | Q28258089 | ||
| Neuroinflammation in Alzheimer's disease | Q28259238 | ||
| Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner | Q28267444 | ||
| Identification of a unique TGF-β-dependent molecular and functional signature in microglia | Q28303557 | ||
| TREM2 and the neuroimmunology of Alzheimer's disease | Q28304401 | ||
| N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression | Q28645594 | ||
| Diaphanous-related formins bridge Rho GTPase and Src tyrosine kinase signaling | Q28646114 | ||
| Microglial physiology: unique stimuli, specialized responses | Q29620417 | ||
| Microglia: Dynamic Mediators of Synapse Development and Plasticity. | Q30373424 | ||
| Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease | Q33571894 | ||
| Effect of TTP488 in patients with mild to moderate Alzheimer's disease | Q33611402 | ||
| Succinate is an inflammatory signal that induces IL-1β through HIF-1α. | Q33652731 | ||
| Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice | Q33742156 | ||
| Systemic inflammation and disease progression in Alzheimer disease | Q33765718 | ||
| The Astrocytic S100B Protein with Its Receptor RAGE Is Aberrantly Expressed in SOD1G93A Models, and Its Inhibition Decreases the Expression of Proinflammatory Genes | Q33868126 | ||
| Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer's disease | Q33887359 | ||
| Advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling and up-regulation of Egr-1 in hypoxic macrophages | Q34003967 | ||
| Mixed oligomers and monomeric amyloid-β disrupts endothelial cells integrity and reduces monomeric amyloid-β transport across hCMEC/D3 cell line as an in vitro blood-brain barrier model. | Q34046424 | ||
| Ontogeny and functions of central nervous system macrophages. | Q34147513 | ||
| CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. | Q34254575 | ||
| Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells | Q34797370 | ||
| Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis | Q35137159 | ||
| Association of Alzheimer's disease GWAS loci with MRI markers of brain aging | Q35339698 | ||
| Roles of Rho-family GTPases in cell polarisation and directional migration | Q35547373 | ||
| Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress | Q35664175 | ||
| Synergistic exacerbation of mitochondrial and synaptic dysfunction and resultant learning and memory deficit in a mouse model of diabetic Alzheimer's disease | Q35738734 | ||
| RAGE Suppresses ABCG1-Mediated Macrophage Cholesterol Efflux in Diabetes | Q35740332 | ||
| Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 Signal Transduction | Q35943768 | ||
| Formin mDia1 mediates vascular remodeling via integration of oxidative and signal transduction pathways. | Q36054820 | ||
| The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro | Q36166108 | ||
| Immunization targeting a minor plaque constituent clears β-amyloid and rescues behavioral deficits in an Alzheimer's disease mouse model. | Q36185908 | ||
| S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway | Q36411027 | ||
| Role of ABC transporters in the pathogenesis of Alzheimer's disease | Q36418108 | ||
| Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling | Q36478250 | ||
| Restoration of glyoxalase enzyme activity precludes cognitive dysfunction in a mouse model of Alzheimer's disease | Q36638616 | ||
| RAGE and modulation of ischemic injury in the diabetic myocardium | Q36756482 | ||
| The microglial sensome revealed by direct RNA sequencing | Q37341692 | ||
| The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetes | Q37660885 | ||
| Heterogeneity of CNS myeloid cells and their roles in neurodegeneration | Q37939514 | ||
| Microglia function during brain development: New insights from animal models | Q38281028 | ||
| Microglia Function in Central Nervous System Development and Plasticity | Q38549720 | ||
| Inflammation in Alzheimer's Disease and Molecular Genetics: Recent Update | Q38558744 | ||
| Microglial genes regulating neuroinflammation in the progression of Alzheimer's disease. | Q38620321 | ||
| Targeted inhibition of RAGE in substantia nigra of rats blocks 6-OHDA-induced dopaminergic denervation | Q39018573 | ||
| RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease | Q39638245 | ||
| The history of Parkinson's disease: early clinical descriptions and neurological therapies | Q39699761 | ||
| Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue | Q39785069 | ||
| RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice | Q40251711 | ||
| Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products | Q40304611 | ||
| Regulation of monocyte migration by amphoterin (HMGB1). | Q40558415 | ||
| Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system | Q40668935 | ||
| Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response | Q40899986 | ||
| Actin stabilization by jasplakinolide enhances apoptosis induced by cytokine deprivation. | Q40975198 | ||
| Microglia, scavenger receptors, and the pathogenesis of Alzheimer's disease | Q41751577 | ||
| Receptor for Advanced Glycation End Products and its Inflammatory Ligands are Upregulated in Amyotrophic Lateral Sclerosis. | Q41871282 | ||
| Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice. | Q42186976 | ||
| Association study of Parkin gene polymorphisms with idiopathic Parkinson disease | Q42604036 | ||
| Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity | Q43090705 | ||
| RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response | Q44032299 | ||
| Detection of N epsilon-(carboxymethyl)lysine (CML) and non-CML advanced glycation end-products in the anterior horn of amyotrophic lateral sclerosis spinal cord | Q44127793 | ||
| RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain | Q44479225 | ||
| The advanced glycation end-product N epsilon-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis | Q45133669 | ||
| Genetic Association of HLA Gene Variants with MRI Brain Structure in Alzheimer's Disease | Q46113901 | ||
| beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. | Q46404934 | ||
| Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis | Q46903808 | ||
| Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains | Q46904404 | ||
| Fingolimod anti-inflammatory and neuroprotective effects modulation of RAGE axis in multiple sclerosis patients | Q47338812 | ||
| Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment. | Q47414857 | ||
| Knockdown of Diaph1 expression inhibits migration and decreases the expression of MMP2 and MMP9 in human glioma cells | Q47647991 | ||
| beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. | Q48009625 | ||
| Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. | Q50180621 | ||
| Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity. | Q51700919 | ||
| S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis. | Q52151935 | ||
| Receptor for advanced glycation end-products (RAGE) activates divergent signaling pathways to augment neurite outgrowth of adult sensory neurons. | Q53090487 | ||
| High-mobility group box 1 in multiple sclerosis. | Q53210919 | ||
| Nitration and Glycation Turn Mature NGF into a Toxic Factor for Motor Neurons: A Role for p75NTR and RAGE Signaling in ALS. | Q53272106 | ||
| Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. | Q53348339 | ||
| A functional p.82G>S polymorphism in the RAGE gene is associated with multiple sclerosis in the Chinese population. | Q54376586 | ||
| Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis. | Q54523448 | ||
| Distribution and cellular localization of high mobility group box protein 1 (HMGB1) in the spinal cord of a transgenic mouse model of ALS | Q57716389 | ||
| Amyotrophic lateral sclerosis | Q59544266 | ||
| RAGE Gene Polymorphisms in Patients with Multiple Sclerosis | Q60732952 | ||
| P433 | issue | 1 | |
| P921 | main subject | neurodegeneration | Q1755122 |
| P577 | publication date | 2018-01-24 | |
| P1433 | published in | Journal of Alzheimer's disease & Parkinsonism | Q27724348 |
| P1476 | title | The Receptor for Advanced Glycation Endproducts (RAGE) and Mediation of Inflammatory Neurodegeneration | |
| P478 | volume | 8 |
Search more.